Physician profile
Jared A Stanton
NPI 1194017996
$2,526.19
in general payments reported to CMS, 2019-2025
18 companies · $511 in 2025
The $511 reported for 2025 was more than what a typical Foot & Ankle Surgery provider received nationally (typical 2025 total: $424).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $136 · 2020: $172 · 2021: $1,395 · 2022: $51.01 · 2023: $103 · 2024: $158 · 2025: $511.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $772.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $772.02 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Crossroads Extremity Systems, LLC | $1,368.16 | 2021 | |
| Organogenesis INC. | $270.69 | 2024-2025 | Puraply Wound Matrix, Simplimax, Cygnus Dual |
| Depuy Synthes Sales INC. | $147.90 | 2019-2020 | |
| Smith+Nephew, INC. | $131.98 | 2019-2025 | Collagenase Santyl |
| Treace Medical Concepts, INC. | $108.35 | 2025 | |
| Trilliant Surgical LLC. | $97.28 | 2020 | |
| Averitas Pharma INC. | $75.18 | 2024 | Qutenza |
| Integra Lifesciences Corporation | $67.75 | 2019-2025 | Integra, Integra Dermal Regeneration Template, Primatrix |
| Globus Medical, INC. | $67.69 | 2025 | Senza |
| Stryker Corporation | $37.28 | 2022-2024 | Bioskin, Augment Injectable, N/A |
| Acera Surgical, INC. | $32.97 | 2022-2023 | Restrata Wound Matrix |
| Djo, LLC | $22.03 | 2024 | Cmf |
| Paratek Pharmaceuticals, INC. | $18.43 | 2023 | Nuzyra |
| Kerecis Limited | $18.25 | 2025 | Kerecis Surgiclose, Kerecis Graftguide |
| Vertex Pharmaceuticals Incorporated | $17.50 | 2025 |
Show all 18 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Polynovo North America LLC | $16.39 | 2023 | |
| Abbvie INC. | $14.21 | 2022 | |
| Osiris Therapeutics INC. | $14.15 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Jared Stanton listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.